On January 8, 2021 Notable Labs, which is redefining cancer treatment by taking a functional approach to precision oncology in hematological cancers, reported that it is participating in Biotech Showcase 2021 and will be presenting the strategic plan for long-term growth (Press release, Notable Labs, JAN 8, 2021, View Source [SID1234573699]). This year registered attendees to Biotech Showcase can access recorded company presentations prior to the actual event. On-demand access allows attendees to view presentations at their convenience, avoiding conflicts with busy meeting schedules during the main event week.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Laurie Heilmann, CEO will be presenting Notable Labs’ strategic vision at Biotech Showcase Digital.
"We are thrilled to share the strategic roadmap that will invigorate and accelerate growth for Notable over the next 3 years," said Heilmann. "This is our first invitation to present at Biotech Showcase and we are impressed at the level of partnership and visibility we have been able to achieve."
Biotech Showcase, produced by Demy-Colton and EBD Group, is an investor conference focused on driving advances in therapeutic development by providing a sophisticated networking platform for executives and investors that fosters investment and partnership opportunities. The conference takes place each year during the course of one of the industry’s largest gatherings and busiest weeks.
"We are delighted that Notable Labs will be presenting at Biotech Showcase this year," said Sara Demy, CEO of Demy-Colton. "Biotech Showcase is a prime occasion for life science entrepreneurs and investors to come together to discover the potential of innovative technologies that will drive the future of drug discovery."